gentulizumab
mAbexperimental
Clinical trial activity
2 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Apr 1, 2021 (NCT05263271)
Timeline
2020s
- Jan 1, 2021
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
Chemistry & pharmacology
- Chirality
- Single Stereoisomer
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL5314984 ↗
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05221385 | Phase 1 | Apr 12, 2021 | Fudan University, GeneScience Pharmaceuticals Co., Ltd. |
| NCT05263271 | Phase 1 | Apr 1, 2021 | GeneScience Pharmaceuticals Co., Ltd., Jiao Tong University, Zhejiang University |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| GeneScience Pharmaceuticals Co., Ltd. | For profit | 2 | 2 | 1 | 2021 |
| Fudan University | Academic/Hospital | 1 | 0 | 1 | 2021 |
| Jiao Tong University | Academic/Hospital | 1 | 0 | 1 | 2021 |
| Zhejiang University | Academic/Hospital | 1 | 0 | 1 | 2021 |
4 organizations
Page 1 / 1